A 45-year-old woman undergoes an elective laparoscopic cholecystectomy at an ambulatory surgery center. Near the end of the procedure, the surgeon requests 0.25% bupivacaine for local infiltration at the port sites. The surgical technician hands the surgeon a drawn-up syringe. The surgeon injects the medication, then notes the empty syringe is labeled "1% lidocaine with epinephrine." This syringe had been placed on the back table for a different procedure and was not cleared before the current surgery. The patient experiences a brief episode of sinus tachycardia but otherwise recovers uneventfully and is discharged home. The incident is reported to the facility's quality management committee. Which of the following is the most appropriate next step in managing this safety event?
- Conduct a root cause analysis to identify underlying systemic vulnerabilitiesCevap
- BPerform a prospective failure mode and effects analysis
- CConclude the investigation prematurely since no lasting harm occurred
- DReport the surgical technician to the state medical board for a medication administration violation
- EMandate a retraining course focusing on the pharmacologic contraindications of epinephrine